Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (115)

2024

  1. Assessing illness-related uncertainty in relapsing-remitting multiple sclerosis: A psychometric analysis of the Mishel Uncertainty of Illness Scale

    Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 10, Núm. 2

  2. Decisional Conflict Regarding Disease-Modifying Treatment Choices Among Patients with Mid-Stage Relapsing-Remitting Multiple Sclerosis

    Patient Preference and Adherence , Vol. 18, pp. 1163-1171

  3. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849

2023

  1. Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

    Multiple Sclerosis and Related Disorders, Vol. 75

  2. Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions

    Biomolecules, Vol. 13, Núm. 8

  3. Changes in Principal Caregiver Mood Affects the Mood of the Parkinson's Disease Patient: The Vicious Cycle of Illness

    Journal of Parkinson's disease, Vol. 13, Núm. 2, pp. 219-231

  4. Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™

    Neurologia, Vol. 38, Núm. 5, pp. 326-333

  5. Cognitive impairment and dementia in young onset Parkinson’s disease

    Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812

  6. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories

    REC: CardioClinics, Vol. 58, Núm. 2, pp. 119-128

  7. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

    Revista Clinica Espanola

  8. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

    Nefrologia, Vol. 43, Núm. 4, pp. 474-483

  9. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

    Endocrinologia, Diabetes y Nutricion, Vol. 70, Núm. 7, pp. 501-510

  10. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

    Cirugia Cardiovascular, Vol. 30, Núm. 3, pp. 174-181

  11. Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: What parameters should a basic lipid profile include?

    Revista clinica espanola, Vol. 223, Núm. 7, pp. 440-449

  12. Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: what parameters should a basic lipid profile include?

    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, Vol. 4, Núm. 2, pp. 138-146

  13. Depressive Symptoms and Their Impact on Quality of Life in Parkinson’s Disease: An Exploratory Network Analysis Approach

    Journal of Clinical Medicine, Vol. 12, Núm. 14

  14. Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles: ¿qué parámetros debe incluir un perfil lipídico básico?

    Advances in Laboratory Medicine, Vol. 4, Núm. 2, pp. 147-156

  15. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

  16. Expanded and Independent Spanish Validation of the MDS-Non Motor Rating Scale

    Movement Disorders Clinical Practice, Vol. 10, Núm. 4, pp. 586-595

  17. Falls Predict Acute Hospitalization in Parkinson's Disease

    Journal of Parkinson's disease, Vol. 13, Núm. 1, pp. 105-124